Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 97.82% is in line with its 5-year average of 98.08%, near the high end of its 5-year range (-349.54%–99.62%).
1038.31% above its 12-month average of 8.59%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 98.24%.
GROSS MARGIN
97.82%
GROSS MARGIN AVG TTM
8.59%
GROSS MARGIN AVG 3Y
98.13%
GROSS MARGIN AVG 5Y
98.08%
GROSS MARGIN AVG 10Y
98.13%
GROSS MARGIN AVG 15Y
98.40%
GROSS MARGIN AVG 20Y
98.91%
CURRENT VS TTM AVG
+1038.31%
CURRENT VS 3Y AVG
-0.32%
CURRENT VS 5Y AVG
-0.27%
CURRENT VS 10Y AVG
-0.32%
CURRENT VS 15Y AVG
-0.59%
CURRENT VS 20Y AVG
-1.10%
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
+140.76%
vs the sector median at left
BioCryst Pharmaceuticals, Inc.
Market Cap
$2.05B
Gross Margin
97.82%
TTM Avg
8.59%
3Y Avg
98.13%
5Y Avg
98.08%
Market Cap
$2.06B
Gross Margin
17.11%
TTM Avg
17.72%
3Y Avg
20.44%
5Y Avg
20.08%
Market Cap
$2.09B
Gross Margin
100.00%
TTM Avg
-1064.88%
3Y Avg
-1783.56%
5Y Avg
-1442.31%
Market Cap
$2.02B
Gross Margin
90.36%
TTM Avg
88.22%
3Y Avg
91.04%
5Y Avg
93.63%
Market Cap
$2.11B
Gross Margin
32.36%
TTM Avg
32.47%
3Y Avg
32.14%
5Y Avg
31.56%
Market Cap
$2.00B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.99B
Gross Margin
86.13%
TTM Avg
85.03%
3Y Avg
84.60%
5Y Avg
84.81%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. (BCRX) | $2.05B | 97.82% | 8.59% | 98.13% | 98.08% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.06B | 17.11% | 17.72% | 20.44% | 20.08% |
| Alvotech (ALVO)vs › | $2.06B | 60.45% | 60.99% | 17.21% | 44.81% |
| Progyny, Inc. (PGNY)vs › | $2.04B | 24.57% | 22.67% | 22.13% | 21.88% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.09B | 100.00% | -1064.88% | -1783.56% | -1442.31% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 90.36% | 88.22% | 91.04% | 93.63% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 32.36% | 32.47% | 32.14% | 31.56% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.00B | 0.00% | 0.00% | 0.00% | 0.00% |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.99B | 86.13% | 85.03% | 84.60% | 84.81% |
| Pharvaris N.V. (PHVS)vs › | $2.14B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
97.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 98.24% |
| 2026-03-31 | -349.54% |
| 2025-12-31 | 97.56% |
| 2025-09-30 | 98.42% |
| 2025-06-30 | 98.29% |
| 2025-03-31 | 96.86% |
| 2024-12-31 | 95.34% |
| 2024-09-30 | 97.24% |
| 2024-06-30 | 98.45% |
| 2024-03-31 | 98.64% |
| 2023-12-31 | 98.25% |
| 2023-09-30 | 98.69% |
| 2023-06-30 | 98.85% |
| 2023-03-31 | 98.64% |
| 2022-12-31 | 96.86% |
| 2022-09-30 | 95.24% |
| 2022-06-30 | 99.62% |
| 2022-03-31 | 99.52% |
| 2021-12-31 | 99.11% |
| 2021-09-30 | 98.50% |
| 2021-06-30 | 99.31% |
| 2021-03-31 | 68.92% |
| 2020-12-31 | 97.98% |
| 2020-09-30 | 74.99% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 98.57% |
| 2019-12-31 | 93.53% |
| 2019-09-30 | 98.99% |
| 2019-06-30 | 98.20% |
| 2019-03-31 | 74.76% |
| 2018-12-31 | 97.43% |
| 2018-09-30 | 98.76% |
| 2018-06-30 | 98.06% |
| 2018-03-31 | 96.48% |
| 2017-12-31 | 96.68% |
| 2017-09-30 | 85.65% |
| 2017-06-30 | 99.29% |
| 2017-03-31 | 96.88% |
| 2016-12-31 | 72.70% |
| 2016-09-30 | 98.16% |
| 2016-06-30 | 99.44% |
| 2016-03-31 | 98.40% |
| 2015-12-31 | 99.39% |
| 2015-09-30 | 87.70% |
| 2015-06-30 | 98.29% |
| 2015-03-31 | 98.90% |
| 2014-12-31 | 99.19% |
| 2014-09-30 | -302.59% |
| 2014-06-30 | 99.66% |
| 2014-03-31 | 97.89% |
| 2013-12-31 | 99.84% |
| 2013-09-30 | -223.78% |
| 2013-06-30 | 99.51% |
| 2013-03-31 | 97.83% |
| 2012-12-31 | 99.56% |
| 2012-09-30 | -111.53% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 99.67% |
| 2009-12-31 | 91.72% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
